Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
What we know about the Brown University shooting suspect who was found dead, and how police linked him to the MIT killing - 2The Way to Business: Startup Illustrations Learned
- 3I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.
- 4Parents who delay baby's first vaccines also likely to skip measles shots
- 5Real time features for Films and Programs
- California is completely free of drought for the first time in 25 years
- How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- Lily Allen 2026 'West End Girl' Tour: How to get tickets, prices, presale info and more
- Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps
- How to watch the ‘Wicked: One Wonderful Night’ special — now streaming
- Was This Driver Simply Having Some good times Or Behaving Like An Ass?
- Passenger Missing After Going Overboard Disney Cruise Ship
- Vote In favor of Your Favored Web based Dating Application
- In Antarctica, photos show a remote area teeming with life amid growing risks from climate change
